Thyrotrophin Releasing Hormone - 5-Hydroxytryptamine Interactions in the Brain Studied Using Chronic Immunization and Chemical Lesioning Techniques

References

• Barbaccia M. L., Brunello N., Chuang D. M., Costa E. On the mode of action of imipramine: Relationship between serotonergic axon terminal function and down regulation of ß-adrenergic receptors. Neuropharmacology 1983; 22: 373–384
   PubMed Web of Science ®Google Scholar
• Barbeau H., Bedard P. Similar motor effects of 5HT and TRH in rats following chronic spinal transection and 5, 7-dihydroxytrypatmine injection. Neuropharmacology 1981; 20: 477–481
   PubMed Web of Science ®Google Scholar
• Bennett G. W., Lighton C., Marsden C. A. The effect of 5, 7-dihydroxytryptamine on amitriptyline-induced increases in brain and spinal cord levels of TRH. Br. J. Pharmac. 1985; 86: 673P
   Google Scholar
• Bennett G. W., Green A. R., Lighton C., Marsden C. A. Changes in the behavioural response to a TRH analogue following chronic amitriptyline treatment and repeated electroconvulsive shock in the rat. Br. J. Pharmac. 1986; 88: 129–140
   PubMed Web of Science ®Google Scholar
• Chihara K., Arimua A., Chihara M., Schally A. V. Effects of intraventricular administration of anti-somatostatin γ-globulin on the lethal dose-50 of strychnine and pentobarbital in rats. Endocrinology 1978; 103: 912–916
   PubMed Web of Science ®Google Scholar
• Costall B., Naylor R. J., Marsden C. D., Pycock C. J. Serotonergic modulation of the dopamine response from the nucleus accumbens. J. Pharm. Pharmac. 1976; 28: 523–526
   PubMed Web of Science ®Google Scholar
• Crespi F., Keane P. E., Moore M. In vivo evaluation by differential pulse voltammetry of the effect of thyrotrophin releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat. Exp. Brain Res. 1986; 62: 329–334
   PubMed Web of Science ®Google Scholar
• Funatsu K., Nanaga I. Various types of thyrotrophin releasing hormone receptors in discrete brain regions and pituitary of the rat. J. Neurochem. 1985; 45: 390–397
   PubMed Web of Science ®Google Scholar
• Fuxe K., Ogren S. O., Agnati L. F., Benfenati F., Fredholm B., Anderson K., Zini I., Eneroth P. Chronic antidepressant treatment and central 5HT synapses. Neuropharmacology 1983; 22: 398–400
   Web of Science ®Google Scholar
• Gilbert R. F., Emson P. C., Hunt S. P., Bennett G. W., Marsden C. A., Sandberg B. E.B., Steinbusch H. W. The effects of monoamine neurotoxins on peptides in the rat spinal cord. Neuroscience 1982; 7: 69–87
   PubMed Web of Science ®Google Scholar
• Goodwin G. M., Green A. R., Johnson R. 5HT2 receptor characteristics in frontal cortex and 5HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br. J. Pharmac. 1984; 83: 235–242
   PubMed Web of Science ®Google Scholar
• Heal D. J., Green A. R. Administration of thyrotrophin releasing hormone (TRH) in rats releases dopamine in n. accumbens but not n. caudatus. Neuropharmacology 1979; 18: 23–31
   Google Scholar
• Heal D. J., Philpot J., Molyneux S. G., Metz A. Intracerebroventricular administration of 5, 7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5HT2 receptors. Neuropharmacology 1985; 24: 1201–1206
   PubMed Web of Science ®Google Scholar
• Hokfelt T., Fuxe K., Johansson O., Jeffcoate S., White N. Distribution of thyrotrophin releasing hormone (TRH) in the CNS as revealed by immunohistochemistry. Eur. J. Pharmacol. 1975; 34: 389–392
   PubMed Web of Science ®Google Scholar
• Hokfelt T., Ljungdahl A., Steinbuch H., Verhofstad A., Nilsson G., Brodin E., Pernow B., Goldstein M. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience 1978; 3: 517–538
   PubMed Web of Science ®Google Scholar
• Iverfeldt K., Peterson L-L., Brodin E., Ogren S-O., Bartfai T. Serotonin type-2 receptor mediated regulation of substance P release in ventral spinal cord and the effects of chronic antidepressant treatment. Naunyn-Schmied. Arch. Pharmac. 1986; 333: 1–6
   PubMed Web of Science ®Google Scholar
• Johansson O., Hokfelt T. Thyrotrophin-releasing hormone, somatostatin and enkephalin: distribution studies using immunohistochemical techniques. J. Histochem. Cytochem. 1980; 28: 364–366
   PubMed Web of Science ®Google Scholar
• Johansson O., Hokfelt T., Pernow B., Jeffcoate S. L., White N., Stainbusch H. W.M., Verhofstad A. A.J., Emson P. C., Spindel E. Immunohistochemical support for three putative transmitters in one neurone: co-existence of 5-hydroxytryptamine, substance P and thyrotrophin releasing hormone-like immunoreactivity in medullary neurones projecting to the spinal cord. Neuroscience 1981; 6: 1857–1881
   PubMed Web of Science ®Google Scholar
• Kalivas P. W., Horita A. Thyrotrophin releasing hormone: central site of action in antagonism of pentobarbital narcosis. Nature 1979; 278: 461–462
   PubMed Web of Science ®Google Scholar
• Kalivas P. W., Horita A. Thyrotrophin releasing hormone: Neurogenesis of actions in the pentobarbital narcotized rat. J. Pharmac. Exp. therap. 1980; 212: 202–210
   Web of Science ®Google Scholar
• Kellar K. J., Cascio C. S., Butler J. A., Kurtzke R. N. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur. J. Pharmacol. 1981; 69: 515–518
   PubMed Web of Science ®Google Scholar
• Leshner A. I., Hofstein R., Samuel D., Gireidanau T. B.V.W. Intraventricular injection of anti-vasopressin serum blocks learned helplessness in rat. Biochem. Pharmacol. Behav. 1978; 9: 889–892
   PubMed Web of Science ®Google Scholar
• Lighton C., Marsden C. A., Bennett G. W. The effects of 5, 7-dihydroxytryptamine and p-chlorophenylalanine on thyrotrophin releasing hormone in regions of rat brain and spinal cord. Neuropharmacology 1984a; 23: 55–60
   PubMed Web of Science ®Google Scholar
• Lighton C., Marsden C. A., Bennett G. W., Minchin M., Green A. R. Decrease in thyrotrophin releasing hormone (TRH) in the n. accumbens and lumbar spinal cord following repeated electroconvulsive shock. Neuropharmacology 1984b; 23: 963–966
   Google Scholar
• Lighton C., Bennett G. W., Marsden C. A. Increase in levels and ex vivo release of thyrotrophin releasing hormone (TRH) in specific regions of the rat CNS by chronic antidepressant treatment. Neuropharmacology 1985; 24: 401–406
   PubMed Web of Science ®Google Scholar
• Lighton C., Bennett G. W., Marsden C. A. Chronic immunization of endogenous thyrotrophin releasing hormone (TRH) in brain alters the behavioural response to pentobarbital and a TRH analogue. Brain Res. 1986; 378: 385–389
   PubMed Web of Science ®Google Scholar
• Marsden C. A., King B. C. The use of doppler shift radar to monitor physiological and drug induced activity patterns in the rat. Pharmac. Biochem. Behav. 1979; 10: 631–635
   PubMed Web of Science ®Google Scholar
• Miyamoto M., Nagawa Y. Mesolimbic involvement in the locomotor stimulant action of thyrotrophin releasing hormone (TRH) in rats. Eur. J. Pharmac. 1977; 44: 143–152
   PubMed Web of Science ®Google Scholar
• Nisbet A., Marsden C. A. Increased behavioural respnse to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5, 7-dihydroxytryptamine administration. Eur. J. Pharmac. 1984; 104: 177–180
   PubMed Web of Science ®Google Scholar
• Pellegrino L. J., Cushman A. J. A stereotaxic atlas of the rat brain. Appleton-Century Crofts, New York 1977
   Google Scholar
• Peroutka S. J., Snyder S. H. Chronic antidepressant treatment lowers spiroperidol-labelled serotonin receptor binding. Science 1980; 210: 88–90
   PubMed Web of Science ®Google Scholar
• Prange A. J., Breese G. R., Cott J. H., Martin B. R., Cooper B. R., Wilson I. C., Plotnikoff N. P. Thyrotrophin releasing hormone: Antagonism of pentobarbital in rodents. Life Sci. 1974; 14: 447–455
   PubMed Web of Science ®Google Scholar
• Prasad C., Jacobs J. J., Wilber J. F. Immunological blockade of endogenous thyrotrophin releasing hormone produces hypothermia in rats. Brain Res. 1980; 193: 580–583
   PubMed Web of Science ®Google Scholar
• Sharif N. A., Burt D. A. Receptors for thyrotrophin releasing hormone (TRH) in rabbit spinal cord. Brain Res. 1983; 270: 259–264
   PubMed Web of Science ®Google Scholar
• Sharp T., Bennett G. W., Marsden C. A. TRH analogues increase dopamine release from slices of rat brain. J. Neurochem. 1982; 39: 1763
   PubMed Web of Science ®Google Scholar
• Sharp T., Brazell M. P., Bennett G. W., Marsden C. A. The TRH analogue CG 3509 increases in vivo catechol/ascorbate oxidation in the n. accumbens but not the striatum of the rat. Neuropharmacology 1984a; 23: 617–623
   PubMed Web of Science ®Google Scholar
• Sharp T., Bennett G. W., Marsden C. A., Tullock I. F. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regulatory Peptides 1984b; 9: 305–315
   PubMedGoogle Scholar
• Sharp T., Tulloch I. F., Bennett G. W., Marsden C. A., Metcalf G., Dettmar P. W. Analeptic effects of centrally injected TRH and TRH analogues in the pentobarbitone-anaesthetised rat. Neuropharmacology 1984c; 23: 339–348
   PubMed Web of Science ®Google Scholar
• Simasko S. M., Horita A. Treatment of rats with the TRH analogue MK-771. Down-regulation of TRH receptors and behavioural tolerance. Neuropharmacology 1985; 24: 157–166
   Google Scholar
• Stolz J. F., Marsden C. A., Middlemiss D. N. Effect of chronic antidepressant treatment and subsequent withdrawal on [3H-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin mediated behaviour. Psychopharmacology 1983; 80: 150–155
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Burt D. R. Properties of [3H] (3-Me-His32)TRH binding to apparent TRH receptors in the sheep central nervous system. Brain Res. 1981; 218: 207–217
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Burt D. R. Species differences in the brain regional distribution of receptor binding for thyrotrophin releasing hormone. J. Neurochem. 1982; 38: 1649–1656
   PubMed Web of Science ®Google Scholar